Innovair Nexthaler

Formoterol fumarate and beclometasone dipropionate, the active ingredients in Innovair Nexthaler, are a combination inhaled corticosteroid/long‑acting β2‑agonist presented as a dry‑powder inhaler for inhalation use. They are indicated for maintenance therapy to control symptoms and reduce exacerbations in adults with asthma or chronic obstructive pulmonary disease (COPD). GNH USA supplies Innovair Nexthaler as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to EU quality standards and provides reliable logistics through its network for global customers.

Innovair Nexthaler, a combination inhaled corticosteroid and long‑acting β2‑agonist, is used in the respiratory disease pathway for maintenance therapy.

- Asthma: improves symptom control and reduces the frequency of exacerbations. - COPD: maintains lung function and decreases the risk of flare‑ups. - Chronic respiratory disease with reversible airway obstruction: provides long‑term bronchodilation and anti‑inflammatory effect.

Common Side Effects: - Throat irritation or soreness. - Hoarseness or voice changes. - Oral candidiasis (thrush) after use. - Cough or wheezing immediately after inhalation. - Headache. - Tremor or mild palpitations.

Serious or Rare Side Effects: - Paradoxical bronchospasm requiring immediate medical attention. - Severe allergic reaction such as anaphylaxis. - Cardiac arrhythmias or significant tachycardia. - Hypokalemia, especially with high doses. - Cataracts or glaucoma with prolonged use. - Osteoporosis or adrenal suppression with chronic systemic exposure.

Before prescribing Innovair Nexthaler, consider the following precautions: - Assess inhaler technique: ensure the patient can use the dry‑powder inhaler correctly. - Monitor for oral candidiasis: advise rinsing the mouth with water after each dose. - Screen for cardiovascular disease: use cautiously in patients with arrhythmias or ischemic heart disease. - Avoid use for acute bronchospasm: provide a rescue inhaler for sudden symptoms. - Pregnancy and lactation: prescribe only if the potential benefit justifies the potential risk. - Store at ambient temperature: keep below 25 °C, protect from moisture and keep in the original packaging.

Innovair Nexthaler may interact with other medicines as follows:

Major Interactions (Avoid): - Beta‑blockers: can diminish the bronchodilator effect of formoterol. - Potent CYP3A4 inhibitors (e.g., ketoconazole): may increase systemic exposure to beclometasone.

Moderate Interactions (Monitor Closely): - Diuretics: may exacerbate hypokalemia when combined with a β2‑agonist. - Theophylline: concurrent use can increase the risk of tachycardia and tremor. - Other inhaled corticosteroids: combined use may raise the risk of systemic corticosteroid effects.